Period of time： 2014年1期
Publisher： Informa Healthcare
Founded in： 2002
Total resources： 54
ISSN： 1474-0338
Subject： R9 Pharmacy
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Expert Opinion on Drug Safety,volume 13,issue 1
Menu
Hyperthyroidism and antithyroid medications: a friend and an enemy of psychosis
Expert Opinion on Drug Safety,volume 13,issue 1 , Vol. 13, Iss. 1, 2014-01 , pp.
Access to resources
Recommend
Cardiac toxicity of some echinocandin antifungals
By Stover Kayla R,Farley Jerry M,Kyle Patrick B,Cleary John D in (2014)
Expert Opinion on Drug Safety,volume 13,issue 1 , Vol. 13, Iss. 1, 2014-01 , pp.By Raisch Dennis W,Garg Vishvas,Arabyat Rasha,Shen Xian,Edwards Beatrice J,Miller Frank H,McKoy June M,Nardone Beatrice,West Dennis P in (2014)
Expert Opinion on Drug Safety,volume 13,issue 1 , Vol. 13, Iss. 1, 2014-01 , pp.Anticoagulant failure in coagulopathic patients: PTT confounding and other pitfalls
By Warkentin Theodore E in (2014)
Expert Opinion on Drug Safety,volume 13,issue 1 , Vol. 13, Iss. 1, 2014-01 , pp.Conjugated estrogens for the treatment of menopausal symptoms: a review of safety data
By Mirkin Sebastian,Komm Barry S,Pickar James H in (2014)
Expert Opinion on Drug Safety,volume 13,issue 1 , Vol. 13, Iss. 1, 2014-01 , pp.Clinical consequences of polypharmacy in elderly
By Maher Robert L,Hanlon Joseph,Hajjar Emily R in (2014)
Expert Opinion on Drug Safety,volume 13,issue 1 , Vol. 13, Iss. 1, 2014-01 , pp.Idiosyncratic drug-induced liver injury: an update on the 2007 overview
By Hussaini S Hyder,Farrington Elizabeth Anne in (2014)
Expert Opinion on Drug Safety,volume 13,issue 1 , Vol. 13, Iss. 1, 2014-01 , pp.Vascular endothelial growth factor inhibitors and cognitive impairment: evidence and controversies
By Ng Terence,Cheung Yin Ting,Ng Quan Sing,Ho Han Kiat,Chan Alexandre in (2014)
Expert Opinion on Drug Safety,volume 13,issue 1 , Vol. 13, Iss. 1, 2014-01 , pp.The safety of prescribing opioids in pediatrics
By Martin David P,Bhalla Tarun,Beltran Ralph,Veneziano Giorgio,Tobias Joseph D in (2014)
Expert Opinion on Drug Safety,volume 13,issue 1 , Vol. 13, Iss. 1, 2014-01 , pp.Adverse effects of golimumab in the treatment of rheumatologic diseases
By Yang Hong,Kavanaugh Arthur in (2014)
Expert Opinion on Drug Safety,volume 13,issue 1 , Vol. 13, Iss. 1, 2014-01 , pp.
Previous
Next